Annual report
4594.TEDINET S100ODEX
Period2021-04-01 → 2022-03-31
Filed2022-06-23
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Amended by S100PTK6 (2022-12-19).
Key figures · 82
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥15m | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥3m | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥11m | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥156m | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥354m | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥1.5bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | −¥1.7bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | −¥1.5bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.7bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.8bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.7bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.6bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.6bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.5bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥1.7bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income (owners) | −¥1.6bn | 2017-04-01 → 2018-03-31d | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥1.5bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | −¥1.7bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | −¥1.9bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥1.9bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥1.6bn | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.8bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥3.7bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥3.5bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥5.3bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.2bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.2bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥240m | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥212m | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.5bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.5bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.2bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥5.1bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥7.0bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.3bn | at 2021-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥2.3bn | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.3bn | at 2021-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.0bn | at 2020-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2019-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥6.5bn | at 2018-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥1.5bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.8bn | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.8bn | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.5bn | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.6bn | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥18m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥36m | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥107m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥185m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥112m | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥569m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.1bn | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥9m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥16m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.3bn | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-28.55 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-36.14 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-44.2 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-44.95 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-41.25 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥45.4 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥69.1 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥75.49 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥119.66 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥164.78 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 90.5% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.7% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.5% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.7% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 95.3% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 95.2% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 55,253,100 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,817,500 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,101,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 41,993,500 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 41,835,400 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 38 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 44 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 44 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 42 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 42 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 803
| Item | Context | Value | Unit |
|---|---|---|---|
| Research and development expenses sga | Prior1YearDuration_NonConsolidatedMember | 1408443000 | JPY |
| Research and development expenses sga | CurrentYearDuration_NonConsolidatedMember | 1135847000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)有価証券報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-06-23 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第19期(自 2021年４月１日 至 2022年３月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ブライトパス・バイオ株式会社 | |
| Company name in english cover page | FilingDateInstant | BrightPath Biotherapeutics Co., Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 永井 健一 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)神奈川県川崎市川崎区殿町三丁目25番22号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 044-440-3939 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)管理部 鷺池 秀樹 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都千代田区麹町二丁目２番地４ | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03-5840-7697(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)管理部 鷺池 秀樹 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E31851 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45940 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)ブライトパス・バイオ株式会社 | |
| Filer name in english | FilingDateInstant | BrightPath Biotherapeutics Co., Ltd | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Current period end date | FilingDateInstant | 2022-03-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2020-04-01 | |
| Comparative period end date | FilingDateInstant | 2021-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2021-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |